Utility of cystatin C for renal function in amyotrophic lateral sclerosis

Creatinine (Cr) as a marker of renal function has limited value in amyotrophic lateral sclerosis (ALS) because patients with ALS have reduced muscle mass. Thus, there is a need for alternative methods of assessing renal function. Cystatin C (CysC), which is unaffected by muscle mass, is potentially an ideal biomarker of nephrotoxicity in ALS; however, its utility requires validation.

[1]  Z. Simmons,et al.  The Neuromuscular Manifestations of Amyloidosis , 2010, Journal of clinical neuromuscular disease.

[2]  J. Mendell,et al.  Utility of cystatin C to monitor renal function in duchenne muscular dystrophy , 2009, Muscle & nerve.

[3]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  M. Horio,et al.  Simple sampling strategy for measuring inulin renal clearance , 2009, Clinical and Experimental Nephrology.

[5]  H. Ham,et al.  Escaping the correction for body surface area when calculating glomerular filtration rate in children , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  S. Mauss,et al.  Cystatin C as a Marker of Renal Function is Affected by HIV Replication Leading to an Underestimation of Kidney Function in HIV Patients , 2008, Antiviral therapy.

[7]  W. Adam.  Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations , 2008, The Medical journal of Australia.

[8]  T. Reynolds,et al.  The MDRD formula and validation. , 2006, QJM : monthly journal of the Association of Physicians.

[9]  G. Filler,et al.  Influence of commonly used drugs on the accuracy of cystatin C-derived glomerular filtration rate , 2006, Pediatric Nephrology.

[10]  T. Larson,et al.  Glomerular filtration rate estimated by cystatin C among different clinical presentations. , 2006, Kidney international.

[11]  T. Larson,et al.  Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease , 2004, Annals of Internal Medicine.

[12]  M. Enomoto,et al.  A sol particle homogeneous immunoassay for measuring serum cystatin C. , 2004, Clinical biochemistry.

[13]  Adriano Chiò,et al.  Acute migraine treatment with droperidol , 2003, Neurology.

[14]  G. Spinas,et al.  Serum cystatin C is sensitive to small changes in thyroid function. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[15]  F. Ierino,et al.  Cystatin C for estimation of glomerular filtration rate in patients with spinal cord injury , 2003, Annals of clinical biochemistry.

[16]  O. Torffvit,et al.  Metabolic status in diabetes mellitus affects markers for glomerular filtration rate , 2003, Pediatric Nephrology.

[17]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[18]  P. Nilsson-ehle,et al.  Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. , 1999, Scandinavian journal of clinical and laboratory investigation.

[19]  J. Cedarbaum,et al.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.

[20]  N. Brünner,et al.  Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. , 1998, Clinical chemistry.

[21]  R. Zinck,et al.  Cystatin C--a new marker of glomerular filtration rate in children independent of age and height. , 1998, Pediatrics.

[22]  G. Mora,et al.  Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis , 1995, Journal of Neurology.

[23]  I. Olafsson,et al.  Structure and expression of the human cystatin C gene. , 1990, The Biochemical journal.

[24]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[25]  R. Griggs,et al.  The assessment of muscle mass in progressive neuromuscular disease , 1983, Neurology.

[26]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .

[27]  G. Banfi,et al.  Estimation of glomerular filtration rate by MDRD equation in athletes: role of body surface area , 2011, European Journal of Applied Physiology.

[28]  G. Filler,et al.  Cystatin C as a marker of GFR--history, indications, and future research. , 2005, Clinical biochemistry.

[29]  K. Gorson.  Approach to neuromuscular disorders in the intensive care unit , 2005, Neurocritical care.

[30]  Akihiko Hirata,et al.  [Cystatin C]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[31]  C. Price,et al.  Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. , 1995, Kidney international.